Global Coalition on Aging Releases COVID-19 Vaccination Playbook to Help Cities Around the World Increase Vaccine Confidence Among Older Adults

Building on a pioneering model from Age-friendly NYC, the playbook offers step-by-step guidance for Age-friendly Cities and Communities to lead on adult vaccination, for COVID-19 and beyond.

New York, NEW YORK (March 25, 2021) –The Global Coalition on Aging (GCOA) today released a first-of-its-kind playbook to help Age-friendly Cities and Communities around the world address community concerns and increase confidence in the COVID-19 vaccines. The playbook, Building Confidence in COVID-19 Vaccination: A Playbook for Age-Friendly Cities, offers step-by-step guidance to replicate the successful vaccine confidence initiative led by GCOA with the Age-friendly NYC Commission, in early 2021.

In February and March 2021, GCOA organized a series of community-focused webinars, on which the playbook is built. The webinars brought together close to 20 international medical experts and leaders from minority and faith communities across the City of New York to:

  1. demystify the science behind COVID-19 vaccines, their development, their safety, and efficacy and
  2. to directly address the questions and concerns shared by older New Yorkers, their family members, and those that serve older adult communities.

The GCOA vaccine confidence initiative and resulting playbook offer an accessible and replicable model for leaders around the world to tailor as they reach out to the older adults in their own communities.

“New York’s unique experience as an early epicenter of the global pandemic, the diversity of our older adults, and the strong leadership of our city agencies and the Age-friendly NYC Commission made us a very good proving ground for such an effort,” explained Michael Hodin, CEO of the Global Coalition on Aging.

“We are sharing our experience with the world, especially through the World Health Organization’s Age-friendly Network of Cities and Communities. We hope this helps not only for a positive and successful COVID-19 vaccine rollout but can also become a model for other recommended adult vaccine immunization efforts, from flu and shingles to pneumococcal pneumonia,” said Hodin.

While the playbook was created to support the worldwide rollout of COVID-19 vaccines, the strategies and resources outlined in the playbook can be used by cities everywhere to strengthen public health through adult vaccination more broadly. GCOA also partnered with Novim on the Alliance to Beat Covid, a resource platform to encourage vaccination against COVID-19. Now more than ever, leaders and the public appreciate the critical role of prevention in combatting disease. Building Confidence in COVID-19 Vaccination: A Playbook for Age-Friendly Cities will be shared with the WHO Network of Age-friendly Cities and Communities and is available to any and all local leaders wishing to elevate healthy aging through a community-focused approach to adult vaccination. The playbook is available as a free download on the GCOA website.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.